Background: Regression of coronary fatty plaque, the type most prone to rupture and cause acute coronary syndromes, is associated with fewer cardiovascular events. A baseline non-HDL-C level ≤100 ...

Please provide your email address to receive an email when new articles are posted on . Head and neck cancer trials with no statistically significant results got published 11 times less often as those ...

In 2024, the Oregon Ducks had one of the best football seasons in program history, going 13-0 in the regular season with a win in the Big Ten championship as first-year members of the league. While ...

The Detroit Lions were historically basement dwellers in the NFL, but a culture shift under head coach Dan Campbell led to them being one of the best teams in the league the past two years. Last ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced topline results from the Phase III clinical trial, HARMONi, the first global Phase ...

MIAMI--(BUSINESS WIRE)--$SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced topline results from the Phase ...

Gyre Therapeutics announced positive results from its Phase 3 trial of Hydronidone, a treatment for liver fibrosis in patients with chronic hepatitis B (CHB), showing a significant regression in ...

SAN DIEGO, May 22, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced that its lead ...